Fiocruz News
Displaying 1891 - 1920 of 2491
The side event Vaccines: a case for science, society, and political interactions of STI for the SDG was organized by Fiocruz
The event promotes the discussion on new strategies to increase research, technological development and innovation at Fiocruz
"We heard a lot about the resilience and strengthening of healthcare systems, but we must turn speeches into actions”, says Carissa Etienne
Zélia Profeta was invited to be a member of the Council on the Economics of Health for All
Wildfires were responsible for the increase in the percentages of hospitalizations in the last 10 years
The purpose of the agreement is to establish the basis to implement a joint work plan for the upcoming years
First-phase results have proven to be effective in inhibiting Sars-CoV-2 replication in cells in the lab
According to the analysis, the younger age group, from 20 to 29 years old, was the one with higher number of deaths: 1,081.82%
Study highlights degrading actions that the biome has been suffering is a risk to the health of populations, especially when it brings the possibility of the emergence of new diseases or the resurgence of old ones
Research compares cases of patients infected with Sars-CoV-2 and people who received vaccines
At an event promoted by the Center for International Relations in Health, she adds that ensuring human rights is a ‘vaccine’ against hunger
Event marked World Chagas Day and signature of the CUIDA Chagas project to eliminate congenital disease transmission in Latin America
At African conference, Nísia reaffirmed Fiocruz’ commitment to support the continent in strengthening its health system
The impact of the virus on blood coagulation might transform the disease in the first thrombotic viral fever infection
A methodology to make the monitoring of the new variants simpler, faster and cheaper has been developed at Fiocruz Pernambuco
Researchers presented in March the outcome of over five years of work during the Zikalliance Consortium Annual Meeting
A Fiocruz’s study to be published in the EID journal (CDC/US) shows that a first exposure to COVID-19 may not produce an immune response
On April 14 will happen the first PrInt Fiocruz-Capes virtual seminar in 2021, with transmission on YouTube
In addiction to the Oxford/AstraZeneca-Fiocruz, the Foundation is developing six other projects leading to new immunizers
Country is facing the collapse of the health system and, at the same time, the pandemic is now taking up new shapes
National Institute of Women, Children and Adolescents Health Fernandes Figueira (IFF) designation will be valid for four years
Scientists identified changes in samples from 15 patients from Amazonas, Bahia, Maranhão, Paraná, Rondônia, Minas Gerais and Alagoas.
The policy of the institution, with its principles and guidelines, is available in English and Portuguese
The exhibition is the result of collaborative scientific research, produced with intense social participation, and aims to alert the fact that the Zika Virus Congenital Syndrome goes beyond microcephaly
The ranking includes the 66 scientists with most papers published on cutaneous leishmaniasis from all over the world and also includes three other researchers of Fiocruz Bahia
The main point discussed was related to the vaccine against Covid-19. The United Kingdom Embassy has, since the beginning of the prospecting of the immunizer, been supporting Fiocruz, the University of Oxford and AstraZeneca
at the moment, of the 27 federative units, 24 states and the Federal District have occupancy rates for ICU COVID-19 beds for adults in the Brazilian Public Health System equal to or greater than 80%